Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats
Related Experiment Video
Updated: Aug 18, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
A Kernell1, H Dahlkvist, H Arnqvist
1Department of Pediatrics, University Hospital, Linköping, Sweden.
Abstract:
One hundred and eight male Sprague-Dawley rats weighing 160-225 g were examined with vitreous fluorophotometry (VF). Fifty-five rats were made diabetic with streptozocin (43 with 65 mg/kg and 12 with 90 mg/kg); 53 nondiabetic rats served as controls. Fluorescein (7 mg/kg) was injected IV and VF was performed 60 min later. The diabetic rats had an abnormal blood-retinal barrier (BRB) after 4-7 days duration. The difference between the diabetic and non-diabetic rats was persistent up to 35 days (P < 0.02-0.001). The diabetic rats treated with 90 mg/kg streptozotocin had a more severe diabetes and a higher treated with 65 mg/kg (P < 0.05). The BRB function was normalized in 18 rats treated for 6-7 days with 5-6 IU long-acting insulin (P < 0.02). The results imply that streptozocin-diabetic rats have an abnormal BRB and that this abnormality seems to be related to the diabetic state and to be reversible after insulin treatment.
Related Concept Videos
Diabetic Retinopathy
Diabetic Nephropathy

